Physicians from Bochum have used a cancer treatment method to treat severe autoimmune diseases.

The National Institute for Health and Care Excellence (NICE) recommended the drug not be used by the NHS due to its ...

Although it did not meet the primary endpoint of dose-response relationship, when compared to placebo, enpatoran demonstrated improvements in measures of both systemic and cutaneous disease activity ...

Worldwide Healthcare Trust PLC - Annual Financial Report PR Newswire LONDON, United Kingdom, June 11 10 June 2025Worldwide Healthcare Trust PLC(the "Company") Annual Financial ...

Goldman Sachs 46th Annual Global Healthcare Conference Call June 10, 2025 9:20 PM ETCompany ParticipantsJames E.

Abstract. Background Comorbid autoimmune disorders affect approximately 0.2% of the population.A second autoimmune disease occurs in up to 15% of myasthenia gravis (MG) patients. Objective To evaluate ...

Fueled by social media, more boys and men are turning to supplements like amino acids, creatine monohydrate, pre-workout drinks or powders, protein bars and whey protein product in an effort to bulk ...

Cartesian Therapeutics is a clinical-stage company pioneering cell therapy for the treatment of autoimmune diseases. The Company’s lead asset, Descartes-08, is a CAR-T in Phase 3 clinical development ...

BOSTON, May 29, 2025 /PRNewswire/ -- Myasthenia Gravis Foundation of America (MGFA ™), the largest, leading patient advocacy organization in the United States solely dedicated to the myasthenia ...

FDA Approves Johnson & Johnson’s IMAAVYTM (nipocalimab-aahu) a New Treatment for Myasthenia Gravis (MG), Offering Hope for Families Provided by GlobeNewswire Apr 30, 2025, 5:42:04 PM ...